Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;48(2):183-187.
doi: 10.1016/j.amepre.2014.08.036. Epub 2014 Nov 10.

Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011

Gery P Guy Jr  1 , Steven R Machlin  2 , Donatus U Ekwueme  3 , K Robin Yabroff  4
Affiliations

Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011

Gery P Guy Jr et al. Am J Prev Med. 2015 Feb.

Abstract

Background: Skin cancer, the most common cancer in the U.S., is a major public health problem. The incidence of nonmelanoma and melanoma skin cancer is increasing; however, little is known about the economic burden of treatment.

Purpose: To examine trends in the treated prevalence and treatment costs of nonmelanoma and melanoma skin cancers.

Methods: This study used data on adults from the 2002-2011 Medical Expenditure Panel Survey full-year consolidated files and information from corresponding medical conditions and medical event files to estimate the treated prevalence and treatment cost of nonmelanoma skin cancer, melanoma skin cancer, and all other cancer sites. Analyses were conducted in January 2014.

Results: The average annual number of adults treated for skin cancer increased from 3.4 million in 2002-2006 to 4.9 million in 2007-2011 (p<0.001). During this period, the average annual total cost for skin cancer increased from $3.6 billion to $8.1 billion (p=0.001), representing an increase of 126.2%, while the average annual total cost for all other cancers increased by 25.1%. During 2007-2011, nearly 5 million adults were treated for skin cancer annually, with average treatment costs of $8.1 billion each year.

Conclusions: These findings demonstrate that the health and economic burden of skin cancer treatment is substantial and increasing. Such findings highlight the importance of skin cancer prevention efforts, which may result in future savings to the healthcare system.

PubMed Disclaimer

References

    1. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283–287. - PubMed
    1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 Incidence and Mortality Web-Based Report. Atlanta GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2013. www.cdc.gov/uscs.
    1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–1080. - PubMed
    1. Edwards BK, Noone AM, Mariotto AB, et al. Annual report to the nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):2190–2314. - PMC - PubMed
    1. Clinical Classifications Software (CCS) for ICD-9-CM. Healthcare Cost and Utilization Project (HCUP) Rockville MD: Agency for Healthcare Research and Quality; www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. - PubMed

MeSH terms